Associations between the central serotonergic and γ-aminobutyric acid (GABA) systems play key roles in the prefrontal cortical regulation of emotion and cognition and in the pathophysiology and pharmacotherapy of highly prevalent psychiatric disorders. The goal of this study was to test the effects of common variants of the tryptophan hydroxylase isoform 2 (TPH2) gene on GABA concentration in the prefrontal cortex (PFC) using magnetic resonance spectroscopy. In this study involving 64 individuals, we examined the associations between prefrontal cortical GABA concentration and 12 single nucleotide polymorphisms (SNPs) spanning the TPH2 gene, including rs4570625 (−703 G/T SNP), a potentially functional TPH2 polymorphism that has been associated with decreased TPH2 mRNA expression and panic disorder. Our results revealed a significant association between increased GABA concentration in the PFC and the T-allele frequencies of two TPH2 SNPs, namely rs4570625 (−703 G/T) and rs2129575 (p40.0004) and the C-allele frequency of one TPH2 SNP, namely rs1386491 (p = 0.0003) in female subjects. We concluded that rs4570625 (−703 G/T), rs2129575 and rs1386491 play a significant role in GABAergic neurotransmission and may contribute to the sex-specific dysfunction of the GABAergic system in the PFC.
Introduction
The neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) is one of the key modulators of the brain's circuits for emotion and adaptation to stress. Associations have been found between different neuropsychiatric disorders and the genes that modulate serotonergic neurotransmission, such as the TPH2 gene, which encodes for tryptophan hydroxylase isoform 2, an enzyme exclusively expressed in the brain (Maron et al., 2007; Gutknecht et al., 2009; Roche and McKeon, 2009 ). Tryptophan hydroxylase, which is the rate-limiting enzyme in 5-HT synthesis, catalyses the hydroxylation of tryptophan. One of the major target structures of the central serotonergic system is the prefrontal cortex (PFC). Selective 5-HT reuptake inhibitors (SSRIs) can significantly increase brain γ-aminobutyric acid (GABA) concentration (Bhagwagar et al., 2004) ; suggesting that altering 5-HT concentration will have a direct impact on GABA concentration. However, it should be noted that Bhagwagar et al. (2004) observed GABA concentration in the occipital cortex. Evidence regarding possible effects of SSRIs on GABA levels in the PFC is still missing. Glutamatergic pyramidal neurons and GABA interneurons are the two major neuronal populations in the PFC. GABAergic interneurons exert powerful inhibitory control over excitatory efferent projections from the PFC (Feng et al., 2001) . The main effect of physiologically released 5-HT on these PFC projections is inhibitory (Puig et al., 2005) . Serotonergic axons synapse predominantly on interneurons (Smiley and Goldman-Rakic, 1996) , and 5-HT can strongly modulate GABA-mediated inhibitory neurotransmission (Ciranna, 2006) . The psychiatric conditions associated with impaired serotonergic neurotransmission are also associated with a dysfunctional GABA system. Schizophrenia, depression and anxiety have been associated with reduced cortical GABA concentration (Akbarian et al., 1995; Sanacora et al., 1999; Goddard et al., 2001; Hasler et al., 2007 Hasler et al., , 2010 . Specifically, anxiety disorders have been associated with low GABA concentration in the PFC (Goddard et al., 2001; Hasler, 2010; Hasler et al., 2010) . Moreover, the GABA system is the target of novel antidepressants and mood-stabilizing treatments (Krystal et al., 2002) . SSRIs that produce antidepressant and anxiolytic effects have been shown to increase the firing rates of GABA interneurons (Zhong and Yan, 2011) and, as mentioned earlier, increase brain GABA concentration (Bhagwagar et al., 2004) . Taken together, these data suggest that the 5-HT × GABA interactions within the PFC play a key role in the prefrontal cortical regulation of emotion and cognition and in the pathophysiology and pharmacotherapy of highly prevalent psychiatric disorders.
Human variants of TPH2 have been related to anxiety-related traits (Waider et al., 2011) , amygdala reactivity (Brown et al., 2005; Canli et al., 2005) and psychiatric disorders (Walitza et al., 2005; Mossner et al., 2006b; Kim et al., 2009 ). However, the molecular pathways that are affected by the TPH2 variants and which result in the risk of psychiatric disorders have not yet been elucidated. Low cortical GABA concentrations have been proposed as the most promising imaging endophenotype in mood and anxiety disorders (Hasler and Northoff, 2011) .
We hypothesized that variations within the TPH2 gene significantly influence prefrontal cortical GABA concentration, as determined by magnetic resonance spectroscopy (MRS). We examined the associations between GABA concentration in the medial PFC and 12 single nucleotide polymorphisms (SNPs) spanning the TPH2 gene, including rs4570625 (−703 G/T SNP). Moreover, based on sex differences in 5-HT (5-HT transporter and 5-HT 1A and 5-HT 2A receptors) and brain GABA concentrations (Cosgrove et al., 2007) , we examined the associations in male and female subjects separately. Kim et al. (2009) showed a significant association of rs4570625 with panic disorder (PD) in women. This SNP is potentially functional given recent evidence that the G allele is associated with decreased TPH2 mRNA expression relative to the T allele (Lin et al., 2007; Chen et al., 2008) . The samples were genotyped with a haplotype capture array developed and described previously (Hodgkinson et al., 2008) . Conceivably, our results may help to elucidate the molecular mechanisms that influence the serotonergic regulation of GABAergic transmission within the PFC.
Method

Participants
Volunteers were recruited through newspaper advertisements and posters displayed on the National Institutes of Health, Bethesda campus under a protocol that was approved by the Institutional Review Board of the National Institute of Mental Health. All participants were evaluated for psychiatric diagnoses by an unstructured clinical interview with a psychiatrist as well as with a Structured Clinical Interview of the Diagnostic and Statistical Manual of Mental Disorders-IV and the Structured Interview Guides for the Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale. The clinical evaluation involved a physical examination, electrocardiography and laboratory tests, including kidney and liver function tests, hematologic profiling, thyroid function test, urinalysis and toxicology (drug screen). Exclusion criteria were current medical or neurological disorders, pregnancy, smoking and/or substance abuse. Patients were not under psychotropic medication for at least 4 wk prior to scanning. All participants gave informed consent and the study was approved by the Combined Neuroscience Institutional Review Board at the National Institutes of Health (Hasler et al., 2007) .
The study population consisted of 64 individuals from the following four diagnostic groups: healthy controls [n = 20; 15 women; aged (mean ± S.D.) 36.9 ± 13.8 yr]; individuals with a current episode of major depressive disorder (n = 19; 12 women; aged 31.5 ± 9 yr); individuals with remitted major depressive disorder (n = 16; 12 women; aged 40.8 ± 11.7 yr); individuals with PD (n = 9; 8 women; aged 33.8 ± 12.8 yr). In individuals with PD, mean score (±S.D.) for the Panic Disorder Severity Scale was 7.15 ± 3.16, for the Panic Symptom Scale 18.5 ± 6.02 and for the Hamilton Anxiety Scale 10.08 ± 6.42.
Magnetic resonance spectroscopy
We used in vivo proton MRS to assess the cerebral GABA concentration. Participants underwent scanning in a single session with a 3-T whole-body scanner and a transmit-receive head coil (General Electric Medical Systems, USA) that was capable of providing a homogeneous radio frequency field and spectroscopic measurements of the PFC.
Proton MRS spectra were acquired in a voxel (3 × 3 × 2 cm 3 ) positioned with the posterior edge 1 mm anterior to the rostrum of the corpus callosum and centred on the midline in the horizontal plane and on the bicommissural line in the sagittal plane. This voxel included portions of the perigenual anterior cingulate cortex and the adjacent frontal polar cortex (i.e. portions of Brodmann areas 24, 32 and 10; Hasler et al., 2010) .
The unedited part of an interleaved positionresolved spectroscopy sequence-based J editing method (Sailasuta et al., 2001; Hasler et al., 2007 Hasler et al., , 2010 was used to measure the concentrations of N-acetylaspartate, choline and creatine metabolites, and the spectrum resulting from the subtraction of the unedited and the edited spectra was used to specifically measure the GABA concentration. Echo time for this sequence was set to 68 ms and a single scan consisted of 1024 averages at a repetition time of 1.5 s for a total scan time of 25.6 min. The concentrations of GABA, which were referenced to the concentration of creatine, were expressed as mmol/l (mM). In order to reference the spectra to a quantitative standard, the creatine concentration was set to 7.1 mM, which is the average creatine concentration in the grey and white matter reported in the literature. This conventional creatine referencing method, which is well suited for this study because of the extremely low turnover rate of total creatine in the brain (Wyss and Kaddurah-Daouk, 2000) , has been validated and described previously (Shen et al., 2002; Sanacora et al., 2003) . In the current study, only the GABA:creatine ratios were measured. Since the brain metabolism of creatine is unrelated to tryptophan hydroxylase or variations in the TPH2 gene, we believe that it is safe to assume that creatine is not affected by variations in TPH2 SNPs. Interleaved acquisition and careful in vivo and in vitro quality control procedures were employed in order to ensure the quality of the data. No subtraction errors were detected between the edited and unedited scans.
Genotyping
Peripheral blood was drawn from all 64 participants and DNA was extracted with standard procedures.
Samples were genotyped with an addiction array, which was developed by Hodgkinson et al. (2008) . This array was developed in order to include a panel of markers that are able to provide full haplotype information for the candidate genes of interest in addictive and mood disorders. Our array included the following 12 SNPs that span the TPH2 gene: rs4570625; rs10748185; rs2129575; rs1386488; rs1843809; rs1386496; rs2171363; rs1386491; rs6582078; rs1352250; rs1487275; rs1386483. For all 64 participants, information was available on ancestry informative markers (AIMs). The ancestry of each subject was evaluated separately in the context of the worldwide genetic factor structure. As a result, the AIMs were derived in a consistent way in order to reflect any of the major worldwide ancestry factors. We used 186 AIMs to evaluate these individuals for the population stratification of GABA concentration. Each AIM was a SNP of a known allele frequency in HapMap reference populations and a 6-factor solution was used to estimate the ancestry with Structure version 2.0 (Falush et al., 2003) , as described previously (Zhou and Wang, 2008) .
Statistics
Statistical analyses were performed with the Statistical Package for the Social Sciences (SPSS) for Mac (version 19.0; IBM Corporation, USA). Allele frequencies are provided in Table 1 . We calculated pairwise linkage disequilibrium (LD) between the SNPs with the SNP Analyser 1.2 (Istech Corp., Korea). In order to describe LD, we used the absolute value of D′. D′ values and statistical significance are provided in Table 2 . Multiple linear regressions for the number of minor alleles were performed in order to examine the association between GABA concentration and genotype at each SNP. An additive genetic model was tested by recoding the three SNP genotypes as 0 for the homozygote of the common allele, 1 for the heterozygote and 2 for the homozygote of the uncommon allele. In order to keep type-I error at a rate <5%, we computed the Šidák-corrected significance threshold for multiple testing of SNPs in LD with SNPSpD (Šidák, 1967; Nyholt, 2004) :
The number of independent SNPs (M effLi ) was six and the M effLi -Šidák correction was 0.008. M effLi was calculated using the following equation:
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where λ i is the eigenvalue of c identical tests, I(x51) is the indicator function and ⌊x⌋ is the floor function (for detailed information see Li and Ji, 2005) . Possible effects of gender, age, diagnosis and ancestry on GABA level were calculated with a stepwise linear regression.
Results
We found significant associations between prefrontal GABA concentration and allele frequencies for the rs4570625, rs2129575 and rs1386491 SNPs (p40.008; Table 3 ). Rs4570625 (G/T polymorphism), rs2129575 (G/T polymorphism) and rs1386492 (C/G polymorphism) significantly predicted GABA concentration. GABA levels increased with the number of T or C alleles.
There were no significant associations between gender, age or psychiatric disorder with GABA concentration (p > 0.47, Fig. 1 ). Additionally, none of the ancestry factors predicted GABA level (p > 0.1).
Number of participants per genotype for rs4570625, rs2129575 and rs1386492 is presented in Table 4 . Due to the small number of participants with the homozygote of the uncommon allele, participants were divided into two groups based on genotype for both rs4570625 and rs2129575 for further analysis (see also Canli et al., 2005) . One group consisted of either one or two copies of the T allele (T-carriers) and the other group consisted of non-T-carriers. Similar groups were built for rs1386492. One group consisted of either one or two copies of the C allele (C-carriers) and the other group consisted of non-C-carriers.
Given the important sex differences in the central 5-HT and GABA systems (Hasler and Northoff, 2011) , we tested the associations in male and female participants separately. In an attempt to examine the possible interactions of gender and genotype, we used the SPSS macro Modprobe (Hayes and Matthes, 2009 ). The dependent variable was GABA level, the focal predictor was the respective genotype (rs4570625, rs2129575 and rs1386491) and the moderator variable was gender. The overall fit of the first model (rs4570625) was highly significant (R 2 = 0.2, F = 5.06, d.f.1 = 3, d.f.2 = 60, p = 0.003). Including the genotype × gender interaction (b = 0.013, S.E. = 0.005, t = 2.59, p = 0.012) increased R 2 significantly (ΔR 2 = 0.1, F = 6.69, p = 0.01). The moderator variable, gender, did not predict GABA level (b = − 0.005, S.E. = 0.004, t = − 1.23, p = 0.22). There was a tendency for genotype to predict GABA level (b = − 0.017, S.E. = 0.009, t = − 1.83, p = 0.07). Interestingly, the conditional effects of the focal predictor revealed a highly significant effect of genotype on GABA level in female participants (b = 0.01, S.E. = 0.003, t = 3.72, p = 0.0004) but not in male participants (b = − 0.004, S.E. = 0.005, t = − 0.8, p = 0.43). The T allele of rs4570625 TPH2 rs4570625 B = 0.007; p = 0.002; r 2 = 0.14 rs10748185 B = 0.002; p = 0.21; r 2 = 0.025 rs2129575 B = 0.007; p = 0.001; r 2 = 0.159 rs1386488 B = − 0.002; p = 0.45; r 2 = 0.009 rs1843809 B = − 0.001; p = 0.76; r 2 = 0.002 rs1386496 B = − 0.001; p = 0.59; r 2 = 0.005 rs2171363 B = − 0.001; p = 0.65; r 2 = 0.003 rs1386491 B = 0.006; p = 0.008; r 2 = 0.109 rs6582078 B = 0.003; p = 0.13; r 2 = 0.036 rs1352250 B = − 0.003; p = 0.15; r 2 = 0.032 rs1487275 B = 0.000; p = 0.86; r 2 = 0.000 rs1386483 B = 0.000; p = 0.86; r 2 = 0.000
The effects of seven single nuclear polymorphisms (SNPs) were tested in 64 individuals by the linear regression of minor allele occurrences on the magnetic resonance spectroscopy-determined in vivo GABA concentrations. Significant association of the three SNPs, rs4570625, rs2129575 and rs1386491 with the GABA levels survived Bonferroni's correction for multiple testing. was associated with higher prefrontal GABA concentration in women (Fig. 2) . The overall fit of the second model (rs2129575) was highly significant (R 2 = 0.26, F = 6.96, d.f.1 = 3, d.f.2 = 60, p = 0.0004). Including the significant genotype × gender interaction (b = 0.016, S.E. = 0.005, t = 3.18, p = 0.002) significantly improved R 2 (ΔR 2 = 0.12, F = 10.09, p = 0.002). Genotype (b = − 0.021, S.E. = 0.009, t = − 2.32, p = 0.023) significantly predicted GABA level but gender (b = − 0.007, S.E. = 0.004, t = − 1.67, p = 0.1) did not. The conditional effects of the focal predictor depending on the values of the moderator variable revealed that the effects for genotype became significant for female participants (b = 0.01, S.E. = 0.003, t = 4.33, p = 0.0001) but not for male participants (b = − 0.005, S.E. = 0.004, t = − 1.17, p = 0.25). The T allele of rs2129575 was associated with increased prefrontal GABA concentration in women (Fig. 3) .
The overall fit of the third model (rs1386491) was highly significant (R 2 = 0.21, F = 5.16, d.f.1 = 3, d.f.2 = 60, p = 0.003). Including the genotype × gender interaction (b = 0.01, S.E. = 0.005, t = 2.41, p = 0.004) significantly improved R 2 (ΔR 2 = 0.08, F = 5.83, p = 0.02). Genotype (b = − 0.015, S.E. = 0.009, t = − 1.57, p = 0.12) and gender (b = − 0.003, S.E. = 0.004, t = − 0.7, p = 0.49) had no effect on prefrontal GABA concentration. The conditional effects of the focal predictor genotype depending on the values of the moderator variable, gender, revealed that the effects for genotype became significant for female participants (b = 0.01, S.E. = 0.003, t = 3.82, p = 0.0003) but not for male participants (b = − 0.002, S.E. = 0.004, t = − 0.44, p = 0.66; Fig. 4 ). The C allele of rs1386491 was associated with higher prefrontal GABA concentration in female participants.
Discussion
To our knowledge, this is the first assessment of associations between genetic variations within the brainspecific 5-HT-synthesizing enzyme gene TPH2 and Fig. 2 . Association between γ-aminobutyric acid (GABA) levels and the single nucleotide polymorphism rs4570625 that was analysed separately for male and female subjects. The association between genotype and GABA level became significant for female subjects (* p = 0.0004) but not for male subjects (n.s., p = 0.43). Fig. 3 . Association between γ-aminobutyric acid (GABA) levels and the single nucleotide polymorphism rs2129575 that was analysed separately for male and female subjects. The association between genotype and GABA level became significant for female subjects (* p = 0.0001) but not for male subjects (n.s., p = 0.25).
PFC GABA concentrations. Our results revealed a significant association between the T-allele frequencies of two TPH2 SNPs [rs4570625 (−703 G/T) and rs2129575] and the C-allele frequency of one SNP (rs1386491) and increased GABA concentration in the PFC in female subjects. Given the evidence for an association between −703 G/T and TPH2 mRNA expression, the findings of this study suggest that this polymorphism exerts a functional effect on GABAergic neurotransmission in the PFC and that this may contribute to deficits in GABAergic system function that have been reported in patients with PD and other highly prevalent psychiatric conditions. The T allele of the SNP rs4570625 (−703 G/T) has been associated with different psychopathological disorders, such as schizophrenia (Fang et al., 2011) , suicidal behaviour in major depression , personality disorder and attention deficit/hyperactivity disorder (Jacob et al., 2010) . Furthermore, the T allele of the SNP rs4570625 (−703 G/T) has also been associated with low anxiety levels (Gutknecht et al., 2007; Reuter et al., 2007) . Functional MRS imaging studies have shown relatively increased haemodynamic activity in the amygdala in response to negatively and positively valenced emotional stimuli in T-allele carriers than in G-allele homozygous individuals (Brown et al., 2005; Canli et al., 2005) . It is conceivable that this differential haemodynamic responsiveness of the amygdala to emotional stimuli is related to the differential GABA concentrations in the PFC. Studies in humans and experimental animals have shown that neural activity in some medial PFC regions reduces outflow from the central nucleus of the amygdala (Quirk et al., 2003; Phelps et al., 2004; Sotres-Bayon and Quirk, 2010) . The intra-synaptic GABA concentration is regulated in part by the intracellular GABA concentration (Jackson et al., 2000) . Therefore, higher MRSdetermined GABA concentrations in both intracellular and extracellular compartments would most likely be associated with increased GABAergic transmission within the medial PFC. If so, this higher inhibitory transmission within the medial PFC might reduce efferent prefrontal cortical transmission to the amygdala, thereby diminishing the cortical modulation of the amygdala response to emotional stimuli and potentially producing effects like those observed (Brown et al., 2005; Canli et al., 2005) .
The T allele of rs4570625 (−703 G/T) is associated with increased TPH2 mRNA expression in the raphe nuclei where it catalyses the rate-limiting step in 5-HT synthesis (Lim et al., 2007) . Thus, the T allele presence may result in increased serotonergic neurotransmission to the PFC, which receives serotonergic projections from the dorsal raphe nucleus. Serotonergic axons synapse predominantly on GABAergic interneurons in the PFC (Smiley and Goldman-Rakic, 1996) and the higher 5-HT transmission associated with the administration of SSRIs increases both the firing rates of GABAergic interneurons (Zhong and Yan, 2011) and the brain GABA concentrations (Bhagwagar et al., 2004) . Thus, the association between the T allele and the increased TPH2 mRNA expression in the raphe nuclei suggests a mechanism by which this variant may result in the higher GABA concentrations found herein.
Several studies have shown that genetic variations in TPH2 polymorphisms are associated with a number of psychiatric disorders such as major depression, suicide, anxiety and attention deficit/hyperactivity disorders (De Luca et al., 2004 Mouri et al., 2009; Must et al., 2009) . It has been hypothesized that dysfunction within the serotonergic system plays a major role in anxiety disorders and that both SSRIs and monoamine oxidase inhibitors show antipanic, anxiolytic and antidepressant effects in such disorders. Unfortunately, we did not assess anxiety levels in subjects with past or present major depressive disorder and healthy controls. However, it is important to note that Hasler et al. (2009) did not find any relationship between PFC GABA concentration and current anxiety levels. Fig. 4 . Association between γ-aminobutyric acid (GABA) levels and the single nucleotide polymorphism rs1386491 that was analysed separately for male and female subjects. The association between genotype and GABA level became significant for female subjects (* p = 0.0003) but not for male subjects (n.s., p = 0.66).
A recent study could show that genetic variations (including rs2129575) in the TPH2 gene may partly account for variations in 5-HT synthesis in the orbitofrontal cortex (Booij et al., 2012) . Jacobsen et al. (2012) reported reduced basal and stimulated levels of extracellular 5-HT and increased frontal 5-HT 2A receptors in TPH2 R439H knockin mice. However, they did not find changes in basal extracellular prefrontal GABA levels. Interestingly, a recent study in mice found that brain 5-HT deficiency, resulting from TPH2 inactivation, differentially affects GABAergic systems in limbic regions (Waider et al., 2012) . Moreover, genetic studies have revealed an association between variations in the TPH2 gene and PD. Although Mössner et al. (2006a) found no association between the two SNPs [rs4570625 (−703 G/T) and rs4565946] of the TPH2 gene and PD in a population from Germany, Kim et al. (2009) found a significantly lower frequency of the T allele of the rs4570625 (−703 G/T) polymorphism in PD patients than in healthy controls. Both these previous studies focused on a single SNP and did not examine the effects of genetic variations along the entire length of the TPH2 gene.
The present study revealed that the C allele of rs1386491 was associated with higher prefrontal GABA concentration. Only a few studies have examined the association between psychiatric disorders and rs1386491. One study reported an association between the TPH2 risk haplotype GGTG (including rs1386491) and borderline personality disorder, suicidal behaviour and aggression score (Perez-Rodriguez et al., 2010) . The risk haplotype GGTG (rs2171363, rs1386491, rs6582078 and rs1352250) was first identified by Zhou et al. (2005) . Other studies could not show an association between the TPH2 gene (including rs1386491) and suicidal behaviour (Mouri et al., 2009; Must et al., 2009) .
One limitation of the present study needs to be mentioned. We did not find any differences in GABA concentration between the control subjects and the other diagnostic groups, which may be because of the small sample sizes of each diagnostic group (Hasler et al., 2009 ). Nevertheless, the results showed a strong relationship between variations of the TPH2 gene and prefrontal GABA concentration. This may confirm the importance of examining molecular mechanisms rather than behavioural phenotypes, given the relatively long passage from genes and gene products to psychopathology and the complex and heterogeneous genetic underpinnings of psychological traits (Hasler and Northoff, 2011) .
Recent studies have suggested sex differences in the GABA systems and in the neurotransmission of 5-HT (Cosgrove et al., 2007) . These molecular differences have also been linked to the pathophysiology of anxiety disorders, such as PD. PD is more prevalent in women than in men (Weissman et al., 1997; Grant et al., 2006) . While male PD patients showed abnormal 5-HT transporter availability in various brain regions, there was no such abnormality in female PD patients (Maron et al., 2011) . Furthermore, treatment with the SSRI sertraline showed superior efficacy in women than in men with PD (Clayton et al., 2006) . Finally, previous studies have found important sex differences in the association between TPH2 variants and PD (Maron et al., 2007; Kim et al., 2009) . In particular, Kim et al. (2009) have found a significant association with rs4570625 in the female subgroup only. These results are in line with our results that showed strong associations between the three TPH2 SNPs [rs4570625 (−703 G/T), rs2126575 and rs1386491] with prefrontal GABA concentration in female study participants.
One downside to the present study was the relatively low number of male subjects, which may have been a result of the heterogeneous mix of patient groups and healthy subjects. However, it is important to keep in mind that the association between the TPH2 gene and prefrontal GABA level became stronger when male subjects were excluded and that the descriptive data for male subjects goes in the reverse direction than for female subjects. A power analysis revealed that for rs4570625 a minimum of 297 male participants would have been required to have an 80% chance to detect a significant effect of genotype on GABA. Furthermore, for rs2129575 a minimum of 187 and for rs1386491 a minimum of 1263 male subjects would have been required. Hence, we cannot exclude that a higher number of male participants might have led to a reversed main effect in males or may have cancelled out. However, it seems unlikely that a larger male sample size would have revealed a main effect for male subjects in the same direction as for female subjects. The results provide evidence for a sex-specific interconnection between the serotonergic and GABAergic systems.
Taken together, the present data provided evidence for a specific molecular mechanism involving the interconnection between the serotonergic and the GABAergic systems in the PFC, which may play important roles in the pathophysiology of highly prevalent psychiatric conditions. Moreover, our results, when combined with previous evidence, suggest that these molecular mechanisms contribute to the sex differences in the epidemiology and clinical characteristics of stress-related psychiatric disorders.
